Evidence map›Paper›PMID 35160055›Full record

ArticleJournal of clinical medicine2022

Spectrum of Kidney Disorders Associated with T-Cell Immunoclones.

Alexis Piedrafita, François Vergez, Julie Belliere, Nais Prades, Magali Colombat, Antoine Huart, Jean-Baptiste Rieu, Stéphanie Lagarde, Arnaud Del Bello, Nassim Kamar and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Alexis PiedrafitaCentre de Référence des Maladies Rénales Rares, Département de Néphrologie et Transplantation d'Organes, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.
François VergezLaboratoire d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopôle, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.ORCID 0000-0002-0063-4404
Julie BelliereCentre de Référence des Maladies Rénales Rares, Département de Néphrologie et Transplantation d'Organes, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.
Nais PradesLaboratoire d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopôle, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.
Magali ColombatFaculté de Médecine Rangueil, Université Paul Sabatier-Toulouse III, F-31000 Toulouse, France.
Antoine HuartCentre de Référence des Maladies Rénales Rares, Département de Néphrologie et Transplantation d'Organes, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.
Jean-Baptiste RieuLaboratoire d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopôle, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.
Stéphanie LagardeLaboratoire d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopôle, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.
Arnaud Del BelloCentre de Référence des Maladies Rénales Rares, Département de Néphrologie et Transplantation d'Organes, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.
Nassim KamarCentre de Référence des Maladies Rénales Rares, Département de Néphrologie et Transplantation d'Organes, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.ORCID 0000-0003-1930-8964
Dominique ChauveauCentre de Référence des Maladies Rénales Rares, Département de Néphrologie et Transplantation d'Organes, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.
Camille LaurentFaculté de Médecine Rangueil, Université Paul Sabatier-Toulouse III, F-31000 Toulouse, France.
Lucie ObericDépartement d'Anatomopathologie, Institut Universitaire du Cancer de Toulouse, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.
Loïc YsebaertFaculté de Médecine Rangueil, Université Paul Sabatier-Toulouse III, F-31000 Toulouse, France.
David RibesCentre de Référence des Maladies Rénales Rares, Département de Néphrologie et Transplantation d'Organes, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.
Stanislas FaguerCentre de Référence des Maladies Rénales Rares, Département de Néphrologie et Transplantation d'Organes, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.
Université Toulouse III - Paul Sabatier · FRCentre Hospitalier Universitaire de Toulouse · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large granular T-cell leukemia is a clonal hematological condition often associated with autoimmune disorders. Whether small-sized T-cell clones that are otherwise asymptomatic can promote immune kidney disorders remains elusive. In this monocentric retrospective cohort in a tertiary referral center in France, we reviewed characteristics of 29 patients with T-cell clone proliferation and autoimmune kidney disorders. Next-generation sequencing of the T-cell receptor of circulating T-cells was performed in a subset of patients. The T-cell clones were detected owing to systematic screening (mean count 0.32 × 10

Indexed as

autoimmune disordersimmunocloneslarge granular lymphocytic leukemiarenal fibrosisSTAT3T-cell receptor

Identifiers

PMID35160055
PMCPMC8836922
OpenAlexW4210398798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.